The Genesis Lab at Novartis
user-5ebe28ba4c775eda72abcdf3(2019)
摘要
Novartis' Genesis Labs program, launched in 2016 as part of Novartis Institutes for Biomedical Research (NIBR), hosted pitch competitions where teams of NIBR scientists proposed ideas to explore that aimed to revolutionize drug discovery. The goal was to break down barriers between functions and regions that slow innovation. After advancing to the pitch stage, a panel selected a handful of winning proposals. Winning teams left their roles for 18 months and received the resources and laboratory space to pursue their ideas. By 2018, two cohorts of winners had been selected—one almost at the end of its 18-month tenure and the other soon to begin. Genesis Labs had already overcome several hurdles—for example, scientists at first worried that stepping out of their ordinary role or pitching ideas that were not chosen could end their careers at Novartis. Though the Genesis Labs program ultimately succeeded in …
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络